Jun 19, 2018

REV·1 Engineering To Speak at Drug/Device Combination Product Summit

REV·1 Engineering To Speak at Drug/Device Combination Product Summit

Phil Burke to Present "Best Practices" for Device Development with Drug/Device Combination Products at Boston Summit.

MURRIETA, Calif. - June 19, 2018 - (FOR IMMEDIATE RELEASE) -- REV·1 Engineering will be presenting "Accelerating Along the Critical Path - Identifying Best Practices for De-Risking Device Development for Combination Products" at the Combination Product Life Cycle Management Summit in Boston, MA, June 19th - 21st.

Combination products integrate a medical device for the delivery of a therapeutic drug. Examples can be as straightforward as an auto-injector pen and as sophisticated as interventional devices designed to deliver a precise dose of a therapeutic deep within the body. It is a large and growing segment within healthcare, with global sales projected to reach $267 billion by 2027.

"REV·1 has a strong track record of developing sophisticated, interventional devices, including combination products," said Eric Johnson, co-founder and CEO of REV·1 Engineering. "Our experience developing devices for highly critical, often life-saving procedures has prepared us well for the coming wave of complex technologies."

Over the past decade, REV·1 Engineering has developed more than 140 devices for 70 companies. It's also not uncommon for REV·1 clients to be acquired by large, multi-national companies such as Medtronic, St. Jude Medical and Abbott.

"Early on, we adopted a highly disciplined approach to program management, compliance and documentation," commented Phil Burke, co-founder and COO of REV·1. "This has proven to be very fortuitous, especially when it comes to developing combination products. The parallel, regulatory path the drug and device components must individually follow benefits significantly from our approach. This meticulous process scrubs risk away from the project while simultaneously accelerating the path to commercialization."

"At the end of the day, it's our team that really sets us apart," added Eric. "Our engineers have an average of more than 20 years experience designing and developing interventional devices that consistently push the technological envelope."

The Combination Products Life Cycle Summit is being held at the Boston Hilton Back Bay, June 19th - 21st. For more information on REV·1 Engineering, please contact Terry Murray at terry@rev1engineering.com.

Start Developing Your Medical Device Today!

Learn how REV·1 Engineering delivers medical devices 2X Faster than traditional, in- house design and development processes. From concept to commercialization, REV·1 delivers turn-key solutions for today’s most complex medical technologies.